NDFOS Co., Ltd.

Equities

A238090

KR7238090005

Specialty Chemicals

End-of-day quote Korea S.E. 23:00:00 09/05/2024 BST 5-day change 1st Jan Change
4,055 KRW -0.73% Intraday chart for NDFOS Co., Ltd. -0.37% -15.26%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
NDFOS Co., Ltd. announces an Equity Buyback for 869,566 shares. CI
NDFOS Co., Ltd. authorizes a Buyback Plan. CI
NDFOS Co., Ltd.(KOSDAQ:A238090) dropped from S&P Global BMI Index CI
NDFOS Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
NDFOS Co., Ltd. announced that it has received KRW 12.999990826 billion in funding from Dae Yu Co., Ltd., Jokwang ILI Co., Ltd. CI
Ndfos to Raise $2.5 Million via Stock Offering MT
NDFOS Co., Ltd. announced that it expects to receive KRW 12.999990826 billion in funding from Dae Yu Co., Ltd., Jokwang ILI Co., Ltd. CI
NDFOS Co., Ltd.(KOSDAQ:A238090) added to S&P Global BMI Index CI
Tranche Update on NDFOS Co., Ltd.'s Equity Buyback Plan announced on March 20, 2020. CI
Tranche Update on NDFOS Co., Ltd.'s Equity Buyback Plan announced on March 20, 2020. CI
NDFOS Co., Ltd.'s Equity Buyback announced on March 20, 2020, has expired with 490,836 shares, representing 0.98% for KRW 1,940.99 million. CI
NDFOS Co., Ltd. announced that it has received KRW 13 billion in funding CI
NDFOS Co., Ltd. announced that it expects to receive KRW 13 billion in funding CI
NDFOS Co., Ltd. announces an Equity Buyback for 865,800 shares. CI
NDFOS Co., Ltd. authorizes a Buyback Plan. CI
Ndfos Co.,Ltd. cancelled the acquisition of 54.6% stake in Curebio Co.,Ltd. from consortium of sellers CI
NDFOS Co., Ltd. announced that it has received KRW 35 billion in funding CI
NDFOS Co., Ltd. announced that it expects to receive KRW 35 billion in funding CI
Ndfos Co.,Ltd. announced that it has received KRW 15 billion in funding CI
Ndfos Co.,Ltd. announced that it expects to receive KRW 15 billion in funding CI
Ndfos Co.,Ltd. announced that it has received KRW 32.00322511 billion in funding CI
Ndfos Co.,Ltd. agreed to acquire 54.6% stake in Curebio Co.,Ltd. from consortium of sellers for KRW 15.3 billion. CI
Ndfos Co.,Ltd. announced that it has received KRW 10 billion in funding from H.Science Co. Ltd. CI
KClavis Science New Technology Fund, Life Science Consortium No. 1, Life Science Consortium No. 2, Preston Partners Co., Ltd, Byron Co., Ltd and Third Party Investment Fund 1 completed the acquisition of 69.38% stake in Ndfos Co.,Ltd. from Neo Tech Co., Ltd., Dabo Trading Co., Ltd., Hotak Yoon, Jaesik Yoon and Haesook Bae. CI
KClavis Science New Technology Fund, Life Science Consortium No. 1, Life Science Consortium No. 2, Preston Partners Co., Ltd, Byron Co., Ltd and Third Party Investment Fund 1 signed a contract to acquire 69.38% stake in Ndfos Co.,Ltd. from Neo Tech Co., Ltd., Dabo Trading Co., Ltd., Hotak Yoon, Jaesik Yoon and Haesook Bae for KRW 92 billion. CI
Chart NDFOS Co., Ltd.
More charts
NDFOS Co., Ltd. is a Korea-based company engaged in the manufacture of double-faced tapes and window films. The Company's products mainly consist of double-faced tapes, which are used in touch screen panels of mobile phones, smart TVs, notebooks and cameras, and window films, which are used in glass of automobiles and buildings. The Company distributes its products within domestic market and to overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. A238090 Stock
  4. News NDFOS Co., Ltd.
  5. Ndfos to Raise $2.5 Million via Stock Offering